Overview

Update
Total Equity Funding
$114.31M in 9 Rounds from 8 Investors
Most Recent Funding
$1M Debt Financing on June 11, 2015
Headquarters:
South San Francisco, California
Description:
Catalyst Biosciences is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases.
Founders:
, , ,
Categories:
Medical Device, Biotechnology, Medical
Website:
http://www.catalystbiosciences.com
Social:

Company Details

Update

Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation.

The Company's product discovery platform is based on methods to rapidly create and characterize tailor-made protease drug candidates, called Alteraseâ„¢ therapeutics, that cleave disease-causing proteins or improve the biochemical and pharmacological properties of marketed protease drugs.

Funding Rounds (10) - $115.31M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2015$1M / Debt Financing0
Feb, 2015$3.22M / Venture0
Apr, 2014$5.01M / Venture0
Aug, 2013$400k / Venture0
Apr, 2013$5.07M / Venture6
Sep, 2012$13.41M / Venture5
Jan, 2012$7M / Venture0
Dec, 2008$40M / Series C7
Feb, 2006$30M / Series B6
Nov, 2003$10.2M / Series A2

Current Team (7)

Update

Offices/Locations (1)

Update
  • HQ

    260 Littlefield Avenue

    South San Francisco, California 94080

    United States

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos